Doctors 2.0 & You and Expanscience Introduce New Preventive Health Short Video Awards Contest

Doctors 2.0 & You4 - 5 June 2015, Paris, France.
United by their mutual commitment to the preservation of health in people everywhere, Doctors 2.0 & You, the international digital health conference and industry partner, Expanscience, an international pharmaceutical and dermo-cosmetics laboratory, invite videomakers to contribute to health prevention promotion by participating in the First Health Prevention Short Video Contest Awards.

Applicants to the contest are invited to produce a short video (up to 120 seconds) that expresses public health messages on one of the two following themes that will benefit from the expertise of Expanscience.

  • How to preserve skin health in babies, teens, pregnant women, and new moms
  • How to prevent osteoarthritis and other rheumatological diseases

According to Doctors 2.0 & You founder Denise Silber, "A short video is an excellent medium to reach and impact a broad audience. We are very pleased to join forces with Expanscience to encourage the production and distribution of great videos and hope that many people will be inspired to help out."

For Jean-Paul Berthomé, CEO of Expanscience, "A brand has more than one dimension and a company as well. At Expanscience we are not just in the business of pharmaceuticals and dermo-cosmetics. Health and prevention are a priority for us. So, it was very natural for us to enter into partnership with Doctors 2.0 & You and reward two video projects, one in the prevention of osteoarthritis and related conditions and the other for the maintenance of healthy skin. We truly hope people around the world will contribute their ideas."

About the Awards Process

  • Contest submissions are open from April 14th, 2015 to May 19th, 2015.
  • The first prize winner in each category (skin health and rheumatology) will receive an award of 2000 euros.
  • The decision will be made by a jury of 7 persons selected for their experience in healthcare and communication.
  • The winner will be announced during the 5th Edition of Doctors 2.0 & You, on June 5, 2015 at Cité Universitaire Paris, France.
  • Videos that respond to the criteria indicated in the complete contest rules online will be displayed on the Doctors 2.0 & You Facebook page during the contest period and through October 31, 2015. The winning videos will be promoted online more broadly.
  • To apply, contestants must fill in the form on the website and submit their video online at http://www.doctors20.com/contests-2/short-video-contest-2015/

For further information, please visit:
http://www.doctors20.com

About Doctors 2.0 & You
Innovative, Insightful, Inspiring, Doctors 2.0 & You is "the must-attend annual digital health conference in Europe". Taking place in Paris, for its fifth edition, on June 4-5, 2015, Doctors 2.0 & You is the only international congress providing a 360° view of state of the art tools and services linking patients and physicians with all other healthcare stakeholders. The conference was founded by Denise Silber, pioneering digital health strategist and influencer.and president of Basil Strategies.

Attendees include patients, professionals, healthcare industries, technologists, payers, government. Key topics in 2015 will include artificial intelligence, augmented reality, 3d printing, connected objects as well as mobile apps, communities, serious games, with examples of deployment in multiple medical conditions. The hashtag #doctors20 is the most tweeted in its category, with nearly 9000 participants to-date.

About Expanscience
In 2014, Expanscience - a French independently-owned pharmaceutical and dermo-cosmetics laboratory - generated turnover of €269.8 million, 46.1% of which was through exports, and employed 967 people. Over more than 60 years, the company has built up a solid international reputation as an innovator and as a specialist in skin and the treatment of arthritis. Its products, which include two leading brands - Piasclédine 300 and Mustela - are sold in more than 97 countries (84 distributing countries and 13 subsidiaries). Expanscience develops and also sells natural-origin active ingredients for use in cosmetics, both in France and abroad. The whole value chain is integrated into the company - from research through to production and distribution. Its CSR policy, which was introduced 10 years ago, was recognised as exemplary by the AFAQ 26000 assessment in 2013.

Most Popular Now

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...